First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215…

Overview of attention for article published in Arthritis Research & Therapy, January 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

So far, Altmetric has seen 1 news story.

By David Bautz, PhD TSX:ATE.V READ THE FULL ATE.V RESEARCH REPORT Business Update Phase 2b Study Results in 3Q19 In March 2019…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.